Qube Research & Technologies Ltd
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,761,080
+$4,773,575 QoQ
Shares Held
702,236
+70.1% QoQ
Ownership
0.632%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$44,304
PutShares
15,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $391,792,991 across 21 Drug Manufacturers - Specialty & Generic names. AMLX ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,666,750 | $130,597,792 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,441 | $73,198,044 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
686,853 | $33,071,971 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
498,198 | $25,751,854 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
4,114,425 | $23,863,665 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
621,935 | $20,567,390 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
210,130 | $16,158,997 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
429,363 | $13,086,984 |
All Filings in AMLX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,761,080 | 702,236 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,987,505 | 412,873 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,270,970 | 167,106 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,807,746 | 438,026 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,337,834 | 942,891 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,950,539 | 780,566 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $595,816 | 183,894 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,499,340 | 789,127 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,304 | 15,600 | Put | Sole | 2024-05-14 | |
| 2024-03-31 | $2,681,138 | 944,063 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,103,857 | 482,599 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,979,220 | 162,710 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,678,562 | 124,180 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $930,811 | 31,725 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||